AFP and AFP-L3 AFPL3

Synonyms

Allscripts (AEHR) Order Name

Alpha-Fetoprotein (AFP) and AFP-L3

Sunrise Clinical Manager (SCM) Order Name

Alpha Fetoprotein (AFP) and AFP-L3

EPIC Order Name

Alpha-Fetoprotein (AFP) and AFP-L3

Clinical Info

The AFP-L3% assay is intended for use in the assessment of risk for the development of hepatocellular carcinoma (HCC) in patients with chronic liver diseases

Specimen Type

Blood

Container

Serum Seperator Tube

Collection Instructions

Container/Tube: Gold top tube
Specimen:  0.5 mL serum ( 0.2 mL min)
Rejection: Gross icterus
 

Transport Instructions

Refrigerated

Specimen Stability

9 Days Room Temperature or Refrigerated or Frozen
Rejection: Gross icterus
 

Methodology

Liquid-phase binding assay

Days Performed

TAT 2 - 4 Days

Performing Laboratory

LabCorp

CPT

82107

PDM

1459883

Result Interpretation

Age	Male	Female
	AFP, Serum (ng/mL)	AFP, Serum (ng/mL)
0 to 7 d	0.0–75265.8	0.0–75265.8
8 to 30 d	0.0–32556.4	0.0–32556.4
1 m	0.0–1747.8	0.0–1600.3
2 m	0.0–391.1	0.0–550.0
3 m	0.0–225.8	0.0–339.9
4 m	0.0–230.6	0.0–230.6
5 m	0.0–118.0	0.0–234.0
6 m	0.0–97.2	0.0–97.2
7 to 11 m	0.0–60.3	0.0–60.3
1 y	0.0–21.4	0.0–21.4
2 y	0.0–9.4	0.0–10.1
3 to 4 y	0.0–5.5	0.0–5.5
5 y	0.0–3.6	0.0–4.2
6 to 12 y	0.0–3.9	0.0–3.9
13 to 17 y	0.0–4.3	0.0–4.3
18 to 30 y	0.0–5.7	0.0–4.7
31 to 50 y	0.0–6.9	0.0–6.4
51 to 80 y	0.0–8.4	0.0–9.2
>80 y	0.0–6.4	0.0–8.7
Reference Interval developed by in-house study. Normal values apply only to males and to nonpregnant females. These results are not interpretable for pregnant females.
AFP-L3%, Serum
All	0.0–9.9	0.0–9.9

Forms